Published in

American Society of Hematology, Blood, 11(139), p. 1766-1770, 2022

DOI: 10.1182/blood.2021014401

Links

Tools

Export citation

Search in Google Scholar

Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia

Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO